Journal of neurochemistry (J Neurochem)

Journal PubWeight™ 19259.84‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. 1977 11.55
2 A beta oligomers - a decade of discovery. 2007 8.88
3 Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. 1966 7.91
4 Allelic variation of human serotonin transporter gene expression. 1996 7.08
6 Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. 1979 5.92
7 Oxidative stress and neurodegeneration: where are we now? 2006 5.44
8 The uptake of [3H]GABA by slices of rat cerebral cortex. 1968 5.05
9 The effect of age on the non-haemin iron in the human brain. 1958 4.83
10 Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. 2001 4.45
11 A rapid radiochemical method for the determination of choline acetyltransferase. 1975 4.29
12 Reactive oxygen species and the central nervous system. 1992 4.27
13 Mitochondrial complex I deficiency in Parkinson's disease. 1990 4.03
14 Myelination in rat brain: method of myelin isolation. 1973 4.01
15 Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. 2005 3.87
16 Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. 2008 3.86
17 The excitation and depression of spinal neurones by structurally related amino acids. 1960 3.83
18 The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. 2001 3.81
19 Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. 2003 3.79
20 Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. 2006 3.67
21 Generation of reactive oxygen species by the mitochondrial electron transport chain. 2002 3.61
22 Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. 1956 3.54
23 The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. 2009 3.45
24 Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. 1970 3.42
25 Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. 1984 3.39
26 Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. 1971 3.34
27 Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. 1986 3.31
28 Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. 2002 3.27
29 The GSK3 hypothesis of Alzheimer's disease. 2007 3.16
30 Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. 2002 3.14
31 Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. 1995 3.08
32 Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. 2005 3.06
33 The effect of electrical stimulation and high potassium concentrations on the efflux of (3H) gamma-aminobutyric acid from brain slices. 1969 3.05
34 Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. 2006 3.03
35 Regulation of neurotransmitter release by metabotropic glutamate receptors. 2000 2.98
36 Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure. 2009 2.92
37 TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. 2007 2.91
38 Factor I--inhibitory factor from brain; assay; conditions in brain; simulating and antagonizing substances. 1956 2.91
39 The quantitative estimation of cerebrosides in nervous tissue. 1956 2.87
40 Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. 2011 2.82
41 Glutamate: a neurotransmitter in mammalian brain. 1984 2.82
42 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. 1997 2.80
43 Electrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro. 1966 2.78
44 Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. 1989 2.75
45 Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. 2000 2.71
46 ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. 2002 2.71
47 Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. 1991 2.66
48 Adenosine in the central nervous system: release mechanisms and extracellular concentrations. 2001 2.63
49 Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. 1997 2.62
50 TDP-43 is recruited to stress granules in conditions of oxidative insult. 2009 2.57
Next 50